CHPA Statement on Senate Passage of Microbead-Free Waters Act of 2015

Washington, D.C. (December 18, 2015) — Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville released the following statement, applauding the U.S. Senate for its passage of the Microbead-Free Waters Act of 2015 (S. 1424). The bill, sponsored by U.S. Sen. Rob Portman (R-Ohio) and U.S. Sen. Kirsten Gillibrand (D-N.Y.), is identical to House-passed version and provides a feasible timeframe for the removal of synthetic plastic microbeads from over-the-counter (OTC) and personal care products.

The bill passed the Senate without objection after clearing the House of Representatives on December 7.

“The OTC medicine industry extends our gratitude to Senators Portman and Gillibrand for working to secure swift Senate approval of this important legislation. CHPA also thanks Majority Leader Mitch McConnell (R-KY), Ranking Member Harry Reid (D-NV), Health, Education, Labor and Pensions (HELP) Chairman Lamar Alexander (R-Tenn.), and HELP Committee Ranking Member Patty Murray (D-Wash.) for their willingness to expedite the Senate process to ensure consistency for the industry  and consumers so that plastic synthetic microbeads can be phased out in a uniform manner.

“This legislation now puts into law CHPA members’ longstanding commitment to discontinue formulating cosmetic OTC products with plastic synthetic microbeads. OTC manufacturers have already begun the process of reformulating cosmetic OTCs – such as acne face washes and toothpastes – to remove plastic microbeads, and the timeline now approved by both chambers of Congress will ensure manufacturers have sufficient time to remove microbeads from these products or identify and phase in alternative options.”

CHPA joins with the American Chemistry Council, Personal Care Products Association, and SPI: The Plastics Industry Trade Association in support for the legislation.


The Consumer Healthcare Products Association (CHPA) is the 134-year-old trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to promoting the increasingly vital role of over-the-counter medicines and dietary supplements in America’s healthcare system through science, education, and advocacy.